Related Experiment Videos
Informed consent in acute myocardial infarction research
1Department of Medical Philosophy and Clinical Theory, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark. A.Gammelgaard@medphil.ku.dk
The Journal of Medicine and Philosophy
|September 17, 2004
Summary
Obtaining informed consent for acute myocardial infarction (AMI) clinical trials presents ethical challenges. The process can delay urgent therapy, potentially harming patients during critical care.
Area of Science:
- Cardiology
- Medical Ethics
- Clinical Research
Background:
- Acute myocardial infarction (AMI) is a prevalent condition requiring urgent medical attention.
- Clinical trials in AMI patients face ethical hurdles due to patient stress and the need for rapid treatment.
- The informed consent process itself may inadvertently delay critical care, posing a risk.
Purpose of the Study:
- To examine how physicians manage informed consent in acute myocardial infarction trials.
- To review empirical findings on the informed consent process in AMI studies.
- To discuss ethical considerations for future AMI clinical trials.
Main Methods:
- Review of physician practices in AMI clinical trials.
- Synthesis of empirical data from studies on AMI patient consent.
- Ethical analysis of informed consent in acute cardiac care research.
Main Results:
- Physicians face significant constraints in obtaining informed consent from AMI patients.
- Empirical studies highlight challenges and potential harms associated with the consent process in AMI trials.
- The balance between patient protection and timely treatment is a key ethical issue.
Conclusions:
- The informed consent process in AMI trials requires careful ethical consideration.
- Future research should explore alternative consent models to minimize delays in acute cardiac care.
- Ensuring patient welfare while facilitating essential research is paramount.